Effectiveness of oral montelukast Vs cetirizine in the management of allergic rhinitis in 6-12 -year -old children present to the asthma clinic at the Faculty of Medicine, University of Ruhuna. A randomized double blind controlled clinical trial

Asthma clinic, Faculty of Medicine, University of Ruhuna0 个研究点开始时间: 待定最近更新: 2024年8月20日

适应症

试验速览

暂无简介。

•* Age 6- 12 years
•* Both male and female
•* Having 3 out of 4 of the following for more than six months
•[Sneezing, non purulent rhinorrhea, itchy nose, nasal congestion]
•* Moderately severe- Defined as having one or more of the following items
•[Sleep disturbance, Impairment of daily activities, leisure and/or sport, Impairment of school or work]
•* Along with troublesome symptoms. [itchy eyes, Itchy nose, itchy throat, runny nose, blocked nose, sneezing, tearing/red eyes, mouth breathing]

•* Those who had taken treatment for allergic rhinitis (either oral treatment over last 2 weeks or intranasal
•treatment over the last 4 weeks)
•* Deformities of the nasal passages
•* Those who have undergone surgery in the upper airway.
•* Children with mild symptoms of allergic rhinitis. Mild defined as the having none of the following items present:
•[Sleep disturbance, Impairment of daily activities, leisure and/or sport, Impairment of school or work]
•-Troublesome symptoms [itchy eyes, Itchy nose, itchy throat, runny nose, blocked nose, sneezing, tearing/red eyes, mouth breathing].
•[Accompanied eye and ear symptoms of allergic rhino conjunctivitis or bronchial asthma or
•eczema will not be excluded]
•* Those who are on antacids and proton pump inhibitors (drug interactions)

发起方

Asthma clinic, Faculty of Medicine, University of Ruhuna